Cargando…

The Provocative Roles of Platelets in Liver Disease and Cancer

Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanikarla Marie, Preeti, Fowlkes, Natalie W., Afshar-Kharghan, Vahid, Martch, Stephanie L., Sorokin, Alexey, Shen, John Paul, Morris, Van K., Dasari, Arvind, You, Nancy, Sood, Anil K., Overman, Michael J., Kopetz, Scott, Menter, David George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335590/
https://www.ncbi.nlm.nih.gov/pubmed/34367949
http://dx.doi.org/10.3389/fonc.2021.643815
_version_ 1783733141903507456
author Kanikarla Marie, Preeti
Fowlkes, Natalie W.
Afshar-Kharghan, Vahid
Martch, Stephanie L.
Sorokin, Alexey
Shen, John Paul
Morris, Van K.
Dasari, Arvind
You, Nancy
Sood, Anil K.
Overman, Michael J.
Kopetz, Scott
Menter, David George
author_facet Kanikarla Marie, Preeti
Fowlkes, Natalie W.
Afshar-Kharghan, Vahid
Martch, Stephanie L.
Sorokin, Alexey
Shen, John Paul
Morris, Van K.
Dasari, Arvind
You, Nancy
Sood, Anil K.
Overman, Michael J.
Kopetz, Scott
Menter, David George
author_sort Kanikarla Marie, Preeti
collection PubMed
description Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a multifunctional organ that also plays a critical role in many processes: removal of toxins and metabolism of fats, proteins, carbohydrates, and drugs. Chronic inflammation, trauma, or other causes of irreversible damage to the liver can dysregulate these pathways leading to organ and systemic abnormalities. In some cases, platelet-to-lymphocyte ratios can also be a predictor of disease outcome. An example is cirrhosis, which increases the risk of bleeding and prothrombotic events followed by activation of platelets. Along with a triggered coagulation cascade, the platelets increase the risk of pro-thrombotic events and contribute to cancer progression and metastasis. This progression and the resulting tissue destruction is physiologically comparable to a persistent, chronic wound. Various cancers, including colorectal cancer, have been associated with increased thrombocytosis, platelet activation, platelet-storage granule release, and thrombosis; anti-platelet agents can reduce cancer risk and progression. However, in cancer patients with pre-existing liver disease who are undergoing chemotherapy, the risk of thrombotic events becomes challenging to manage due to their inherent risk for bleeding. Chemotherapy, also known to induce damage to the liver, further increases the frequency of thrombotic events. Depending on individual patient risks, these factors acting together can disrupt the fragile balance between pro- and anti-coagulant processes, heightening liver thrombogenesis, and possibly providing a niche for circulating tumor cells to adhere to—thus promoting both liver metastasis and cancer-cell survival following treatment (that is, with minimal residual disease in the liver).
format Online
Article
Text
id pubmed-8335590
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83355902021-08-05 The Provocative Roles of Platelets in Liver Disease and Cancer Kanikarla Marie, Preeti Fowlkes, Natalie W. Afshar-Kharghan, Vahid Martch, Stephanie L. Sorokin, Alexey Shen, John Paul Morris, Van K. Dasari, Arvind You, Nancy Sood, Anil K. Overman, Michael J. Kopetz, Scott Menter, David George Front Oncol Oncology Both platelets and the liver play important roles in the processes of coagulation and innate immunity. Platelet responses at the site of an injury are rapid; their immediate activation and structural changes minimize the loss of blood. The majority of coagulation proteins are produced by the liver—a multifunctional organ that also plays a critical role in many processes: removal of toxins and metabolism of fats, proteins, carbohydrates, and drugs. Chronic inflammation, trauma, or other causes of irreversible damage to the liver can dysregulate these pathways leading to organ and systemic abnormalities. In some cases, platelet-to-lymphocyte ratios can also be a predictor of disease outcome. An example is cirrhosis, which increases the risk of bleeding and prothrombotic events followed by activation of platelets. Along with a triggered coagulation cascade, the platelets increase the risk of pro-thrombotic events and contribute to cancer progression and metastasis. This progression and the resulting tissue destruction is physiologically comparable to a persistent, chronic wound. Various cancers, including colorectal cancer, have been associated with increased thrombocytosis, platelet activation, platelet-storage granule release, and thrombosis; anti-platelet agents can reduce cancer risk and progression. However, in cancer patients with pre-existing liver disease who are undergoing chemotherapy, the risk of thrombotic events becomes challenging to manage due to their inherent risk for bleeding. Chemotherapy, also known to induce damage to the liver, further increases the frequency of thrombotic events. Depending on individual patient risks, these factors acting together can disrupt the fragile balance between pro- and anti-coagulant processes, heightening liver thrombogenesis, and possibly providing a niche for circulating tumor cells to adhere to—thus promoting both liver metastasis and cancer-cell survival following treatment (that is, with minimal residual disease in the liver). Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8335590/ /pubmed/34367949 http://dx.doi.org/10.3389/fonc.2021.643815 Text en Copyright © 2021 Kanikarla Marie, Fowlkes, Afshar-Kharghan, Martch, Sorokin, Shen, Morris, Dasari, You, Sood, Overman, Kopetz and Menter https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kanikarla Marie, Preeti
Fowlkes, Natalie W.
Afshar-Kharghan, Vahid
Martch, Stephanie L.
Sorokin, Alexey
Shen, John Paul
Morris, Van K.
Dasari, Arvind
You, Nancy
Sood, Anil K.
Overman, Michael J.
Kopetz, Scott
Menter, David George
The Provocative Roles of Platelets in Liver Disease and Cancer
title The Provocative Roles of Platelets in Liver Disease and Cancer
title_full The Provocative Roles of Platelets in Liver Disease and Cancer
title_fullStr The Provocative Roles of Platelets in Liver Disease and Cancer
title_full_unstemmed The Provocative Roles of Platelets in Liver Disease and Cancer
title_short The Provocative Roles of Platelets in Liver Disease and Cancer
title_sort provocative roles of platelets in liver disease and cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335590/
https://www.ncbi.nlm.nih.gov/pubmed/34367949
http://dx.doi.org/10.3389/fonc.2021.643815
work_keys_str_mv AT kanikarlamariepreeti theprovocativerolesofplateletsinliverdiseaseandcancer
AT fowlkesnataliew theprovocativerolesofplateletsinliverdiseaseandcancer
AT afsharkharghanvahid theprovocativerolesofplateletsinliverdiseaseandcancer
AT martchstephaniel theprovocativerolesofplateletsinliverdiseaseandcancer
AT sorokinalexey theprovocativerolesofplateletsinliverdiseaseandcancer
AT shenjohnpaul theprovocativerolesofplateletsinliverdiseaseandcancer
AT morrisvank theprovocativerolesofplateletsinliverdiseaseandcancer
AT dasariarvind theprovocativerolesofplateletsinliverdiseaseandcancer
AT younancy theprovocativerolesofplateletsinliverdiseaseandcancer
AT soodanilk theprovocativerolesofplateletsinliverdiseaseandcancer
AT overmanmichaelj theprovocativerolesofplateletsinliverdiseaseandcancer
AT kopetzscott theprovocativerolesofplateletsinliverdiseaseandcancer
AT menterdavidgeorge theprovocativerolesofplateletsinliverdiseaseandcancer
AT kanikarlamariepreeti provocativerolesofplateletsinliverdiseaseandcancer
AT fowlkesnataliew provocativerolesofplateletsinliverdiseaseandcancer
AT afsharkharghanvahid provocativerolesofplateletsinliverdiseaseandcancer
AT martchstephaniel provocativerolesofplateletsinliverdiseaseandcancer
AT sorokinalexey provocativerolesofplateletsinliverdiseaseandcancer
AT shenjohnpaul provocativerolesofplateletsinliverdiseaseandcancer
AT morrisvank provocativerolesofplateletsinliverdiseaseandcancer
AT dasariarvind provocativerolesofplateletsinliverdiseaseandcancer
AT younancy provocativerolesofplateletsinliverdiseaseandcancer
AT soodanilk provocativerolesofplateletsinliverdiseaseandcancer
AT overmanmichaelj provocativerolesofplateletsinliverdiseaseandcancer
AT kopetzscott provocativerolesofplateletsinliverdiseaseandcancer
AT menterdavidgeorge provocativerolesofplateletsinliverdiseaseandcancer